Publication | Open Access
The Association of <i>ERBB2</i>-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer
48
Citations
3
References
2021
Year
Progression-free SurvivalBreast OncologyPathologyCancer BiologyTumor BiologyReceptor Tyrosine KinaseCancer Cell BiologyRadiation OncologyCancer ResearchMedicineCohort StudyCancer TreatmentHormone Receptor–positivePharmacologyCell BiologyEndocrine-related CancerCyclin-dependent Kinase 4/6Cancer EpidemiologyBreast CancerOncologyErbb2 Expression
This cohort study investigates the association between low levels of ERBB2 expression and progression-free survival among patients with HR+/ERBB2− metastatic breast cancer treated with CDK4/6 inhibitors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1